Seattle Genetics Sees Updated Side Effect Warning in Drug Label Xconomy Several new biotech drugs have been linked to cases of PML, including Roche and Biogen Idec's hit lymphoma drug rituximab (Rituxan). The Seattle Genetics drug is designed to hit a different target on cancer cells, and it is approved for use in a couple ... More PML Cases Turn Up With Adcetris |
